1 mg semaglutide equivalent tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are GLP-1 Medications for Weight Loss:

At the highest dose studied (12 mg), participants achieved a mean body weight reduction of approximately 17.5% at 24 weeks

doi:10.3233/JAD-160241 Hildebrandt W, Sauer R, Bonaterra G, Dugi KA, Edler L, Kinscherf R

Use strict aseptic technique for every puncture

Semaglutide is currently approved for patients who are 12 years of age or older, and tirzepatide is currently approved for patients who are 18 years of age or older

This process is termed gluconeogenesis, with "neo" meaning "new." In this process, the liver generates new glucose from lactate and glycerol molecules, both of which are byproducts of metabolic processes not associated with carbohydrate metabolism

At The Re/ Clinic , were dedicated to bringing wellness solutions to our patients through telehealth services and shipping select products to approved states